Inventor · disambiguated record
Lucio Claudio Rovati
Also filed as: ROVATI LUCIO · ROVATI LUCIO C · ROVATI LUCIO CLAUDIO
57 granted patents·14 pending applications·349 citations·filing 1986–2023
98Inventor score
Files withROTTA RESEARCH LAB18ROTTAPHARM SPA18Rottapharm Biotech Srl16GIORDANI ANTONIO4BORRIELLO MANUELA3
Top patents by PatentIndex Score
71 records- 0188US5587479ABasic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonistsROTTA RESEARCH LAB·Filed 1993·Granted Dec 24, 1996·63 cites·18 claims
- 0287US7674809B2Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) productionROTTAPHARM SPA·Filed 2005·Granted Mar 9, 2010·15 cites·8 claims
- 0387US6440454B1Matrix-type transdermal patch for steroid hormonesROTTAPHARM BV·Filed 1999·Granted Aug 27, 2002·103 cites·29 claims
- 0485US9631029B2Anti-ADAMTS-5 antibody, derivatives and uses thereofRottapharm Biotech Srl·Filed 2013·Granted Apr 25, 2017·9 cites·9 claims
- 0579US7994181B26-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agentsROTTAPHARM SPA·Filed 2006·Granted Aug 9, 2011·6 cites·8 claims
- 0678US9365654B2Anti-TrkA antibodies, derivatives and uses thereofRottapharm Biotech Srl·Filed 2013·Granted Jun 14, 2016·2 cites·5 claims
- 0776US7145037B2Adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing themROTTA RES LABORATURIUM S P A·Filed 2004·Granted Dec 5, 2006·15 cites·10 claims
- 0875US11718582B2(R)-4-(1-(1-(4-(trifluoromethyl)benzyl)pyrrolidine-2-carboxamide)cyclopropyl)-benzoic acid as EP4 receptor antagonistRottapharm Biotech Srl·Filed 2019·Granted Aug 8, 2023·1 cites·18 claims
- 0974US6605722B2Tyrosine derivatives with anti-leukotrienen activityROTTA RESEARCH LAB·Filed 2001·Granted Aug 12, 2003·7 cites·9 claims
- 1074US6413978B1Basic derivatives of benz[e] isoindol-1-ones and pyrrolo[3,4-c] quinolin-1-ones with 5-HT3-antagonistic activity, their preparation and their therapeutic useROTTA RESEARCH LAB·Filed 2001·Granted Jul 2, 2002·8 cites·14 claims
- 1174US2024091227A1Use Of 2-Phenyl-6-(1H-Imidazol-1-YL) Quinazoline For Treating Neurodegenerative Diseases, Preferably Alzheimer's DiseaseRottapharm Biotech Srl·Filed 2023·Application pending·0 cites
- 1272US11590114B2Pharmaceutical combination of an EP4 antagonist and immune checkpoint inhibitors for the treatment of tumoursRottapharm Biotech Srl·Filed 2020·Granted Feb 28, 2023·1 cites·7 claims
- 1372US7482371B2N-phenylbenzamide derivatives as drugs for the treatment of COPDROTTAPHARM SPA·Filed 2005·Granted Jan 27, 2009·1 cites·3 claims
- 1471US7863330B2Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disordersROTTAPHARM SPA·Filed 2006·Granted Jan 4, 2011·1 cites·5 claims
- 1570US8828987B2Pyridine amide derivatives as EP4 receptor antagonistsBORRIELLO MANUELA·Filed 2010·Granted Sep 9, 2014·4 cites·27 claims
- 1669US8859608B2Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addictionSTASI LUIGI PIERO·Filed 2010·Granted Oct 14, 2014·3 cites·17 claims
- 1769US4769389AOxygenated-alkyl derivatives of glutamic and aspartic acids with antagonistic activity to bio-active polypeptides and a method for their preparationROTTA RESEARCH LAB·Filed 1986·Granted Sep 6, 1988·15 cites·11 claims
- 1866US9120824B2Cyclic amine derivatives as EP4 receptor agonistsBORRIELLO MANUELA·Filed 2011·Granted Sep 1, 2015·1 cites·11 claims
- 1966US7202277B2Benzamidine derivatives having anti-inflammatory and immunosuppressive activityROTTA RESEARCH LAB·Filed 2002·Granted Apr 10, 2007·2 cites·2 claims
- 2065US8420634B2Amidine, thiourea and guanidine derivatives of 2-aminobenzothiazoles and aminobenzothiazines for their use as pharmacological agents for the treatment of neurodegenerative pathologiesANZINI MAURIZIO·Filed 2008·Granted Apr 16, 2013·1 cites·5 claims
- 2162US7560591B2Benzamidine derivatives having anti-inflammatory and immunosuppressive activityROTTA RESEARCH LAB·Filed 2008·Granted Jul 14, 2009·0 cites·8 claims
- 2262US6156335APreparation with an acrylic-based, adhesive copolymeric matrix for the transdermal delivery of estradiolROTTA RESEARCH LAB·Filed 1992·Granted Dec 5, 2000·27 cites·8 claims
- 2362US5976576APharmaceutical composition for inhalation containing CR 2039 (Andolast)ROTTA RESEARCH LAB·Filed 1998·Granted Nov 2, 1999·18 cites·31 claims
- 2460US9248115B2Silibinin component for the treatment of hepatitisMADAUS GMBH·Filed 2013·Granted Feb 2, 2016·1 cites·13 claims
- 2559US9062129B2Hyaluronic acid esters, their preparation and use in dermatologyROVATI LUCIO CLAUDIO·Filed 2012·Granted Jun 23, 2015·0 cites·14 claims
- 2658US8614341B2Amorphous silibinin for the treatment of viral hepatitisROVATI LUCIO CLAUDIO·Filed 2010·Granted Dec 24, 2013·2 cites·14 claims
- 2757US5500430AAmidic derivatives of glutamic, aspartic and 2-amino adipic acids, a process for preparing same, and anti-gastrin composition containing the derivativesROTTA RESEARCH LAB·Filed 1991·Granted Mar 19, 1996·5 cites·10 claims
- 2857US2022257598A1Use of 2-Phenyl-6-(1H-Imidazol-1-YL) Quinazoline for Treating Neurodegenerative Diseases, Preferably Alzheimer's DiseaseRottapharm Biotech Srl·Filed 2020·Application pending·0 cites
- 2957US2007135523A1Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activityROTTA RESEARCH LAB·Filed 2007·Application pending·0 cites
- 3056US8809306B2Combination andolast/glucocorticoidsMAKOVEC FRANCESCO·Filed 2006·Granted Aug 19, 2014·0 cites·6 claims
- 3156US5711962ATransdermal therapeutic system for application of pharmaceuticals onto the skinROTTA RESEARCH LAB·Filed 1994·Granted Jan 27, 1998·21 cites·6 claims
- 3255US7846921B2Method of relieving symptoms of gastroesophageal reflux diseaseROTTAPHARM SPA·Filed 2006·Granted Dec 7, 2010·0 cites·5 claims
- 3354US2023000868A1Use of 2-phenyl-6-(1h-imidazol-1-yl) quinazoline for the prevention of abuse and of side effects of at least one opioidRottapharm Biotech Srl·Filed 2020·Application pending·0 cites
- 3453US2010197962A1Use of Neboglamine in the Treatment of ToxicodependencyROTTAPHARM SPA·Filed 2006·Application pending·0 cites
- 3551US12433875B2(R)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl) benzoic acid or its salt also in polymorphic form a for use in the prevention of heterotopic ossificationRottapharm Biotech Srl·Filed 2020·Granted Oct 7, 2025·0 cites·14 claims
- 3651US7824710B2Crystalline and stable form of andolastROTTAPHARM SPA·Filed 2007·Granted Nov 2, 2010·0 cites·15 claims
- 3751US7737180B2Use of neboglamine (CR 2249) as an antipsychotic and neuroprotectiveROTTAPHARM SPA·Filed 2005·Granted Jun 15, 2010·0 cites·9 claims
- 3849US12509446B2FYN and VEGFR2 kinase inhibitorsRottapharm Biotech Srl·Filed 2020·Granted Dec 30, 2025·0 cites·32 claims
- 3949US7906501B2Pyrrole derivatives with angiotensin II antagonist activityROTTAPHARM SPA·Filed 2005·Granted Mar 15, 2011·0 cites·6 claims
- 4048US8633208B26-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligandsGIORDANI ANTONIO·Filed 2008·Granted Jan 21, 2014·0 cites·3 claims
- 4148US8258185B2Use of neboglamine in the treatment of toxicodependencyMAKOVEC FRANCESCO·Filed 2011·Granted Sep 4, 2012·0 cites·10 claims
- 4248US7662994B2Method for the preparation of crystalline dexloxiglumide and products obtainedROTTAPHARM SPA·Filed 2004·Granted Feb 16, 2010·0 cites·13 claims
- 4348US2011182858A1Silibinin component for the treatment of hepatitisMADAUS GMBH·Filed 2008·Application pending·0 cites
- 4447US9498478B2Spiro aminic compounds with NK1 antagonist activityRottapharm Biotech Srl·Filed 2015·Granted Nov 22, 2016·0 cites·6 claims
- 4547US2016244529A1Anti-trka antibodies, derivatives and uses thereofRottapharm Biotech Srl·Filed 2016·Application pending·0 cites
- 4645US12404245B2Process for the preparation of (R)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl) benzoic acid or a salt thereofRottapharm Biotech Srl·Filed 2021·Granted Sep 2, 2025·0 cites·15 claims
- 4744US9174977B22-azabicyclo[4.1.0]heptane derivatives as orexin receptor antagonists for the treatment of certain disordersRottapharm Biotech Srl·Filed 2013·Granted Nov 3, 2015·0 cites·7 claims
- 4844US5723494ADerivatives of glutamic and aspartic acids, a method of preparing them, and their use as drugs for enhancing memory and learningROTTA RESEARCH LAB·Filed 1994·Granted Mar 3, 1998·5 cites·11 claims
- 4944US2022041559A1Benzo-and pyrido-pyrazoles as protein kinase inhibitorsRottapharm Biotech Srl·Filed 2020·Application pending·0 cites
- 5043US8372866B22-aryl and 2-heteroaryl 4H-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents for the treatment of arthritis, cancer and related painROTTAPHARM SPA·Filed 2008·Granted Feb 12, 2013·0 cites·18 claims
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lucio Claudio Rovati files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →